Treating recurrent prostate cancer is a major focus in my clinic, the American Institute for Diseases of the Prostate (AIDP). I started seeing patients with recurrent disease in 1994 at the University of Virginia and have seen about 1,000 men at AIDP since we opened in 2003. About half of my patients at AIDP have or had recurrent cancer. The others had metastatic disease at diagnosis, or are on active surveillance. In 1999, I myself was diagnosed with metastatic prostate cancer and today remain concerned about recurrence.